Deborah Ramsdell is the current CEO and COO of Phoenicis. Deborah has previously held positions at Lotus Tissue Repair, Inc., CMS International, Inc., Phoenicis Therapeutics, Orphan Technologies, Valerion Therapeutics, and Alopexx Enterprises. Ramsdell has over 28 years of experience in the regulatory affairs and clinical operations field.
Deborah Ramsdell holds a Masters in Education from Boston College. Deborah has focused their studies in the field of biology and education.
and Hal Landy - Chief Medical Officer reports to Deborah Ramsdell.